Strengthening Immunisation in the Eastern Mediterranean: WHO Launches Regional Framework

By Melike Belenli Gümüş

October 31, 2024

regional immunization framework

World Health Organization (WHO) Regional Office for the Eastern Mediterranean announced the launch of the regional framework to strengthen immunisation. This framework was inaugurated on October 15, 2024, in Doha, Qatar, as part of a global initiative aimed at enhancing immunisation within primary health care systems.

Current Challenges in Vaccine Access

One in four children in the region lacks access to essential vaccines like pneumococcal and rotavirus. This issue is particularly prevalent in middle-income countries. Furthermore, a staggering 90% of adolescent girls in the region do not receive the HPV vaccine. Of these, 63% live in Gavi-eligible countries. These statistics highlight the urgent need for improved vaccine access across the region.

Expanding Immunisation Coverage

Expanding immunisation coverage throughout the life course is vital. New vaccines targeting high-risk groups, such as health care workers and the elderly, are essential. Establishing vaccine delivery platforms beyond infancy, in settings like schools and workplaces, presents a significant challenge for national immunisation programmes. Addressing these challenges is crucial for the success of Immunization Agenda 2030 (IA2030).

Launch of the Regional Framework

To adapt IA2030 to the needs of the Eastern Mediterranean Region, a strategic framework has been developed. The launch of the regional framework to strengthen immunisation represents a significant step towards facilitating access to essential vaccines in the region. The initiative acknowledges that vaccines are a critical tool, saving over 4 million lives annually. This framework is the result of extensive consultations with national immunisation programmes, the Regional Immunization Technical Advisory Group, and key stakeholders. It reflects the priorities of Member States and includes a comprehensive monitoring and evaluation system. This system will track progress towards the ambitious goals set forth in IA2030.

Objectives

The primary aim of the framework is to improve access to vital vaccines, which remains a pressing concern throughout the region. By addressing disparities in vaccine coverage, especially in conflict-affected areas, the framework seeks to make a meaningful impact on public health.

Context

This initiative’s launch is particularly timely due to the ongoing efforts to tackle health challenges in the Eastern Mediterranean Region. Significant disparities in vaccine accessibility have been noted, making this framework’s objectives even more crucial for the overall health of the population.

Event Details

The launch of the regional framework to strengthen immunisation occurred during the 71st session of the WHO Regional Committee for the Eastern Mediterranean (RC71). The theme of the session was “health beyond borders: action, access, equity,” emphasising the need for collaborative health strategies.

Key figures who inaugurated the event included WHO Director-General Dr. Tedros Adhanom Ghebreyesus, WHO Regional Director for the Eastern Mediterranean Dr. Hanan Balkhy, and H.E. the Minister of Public Health of Qatar Dr. Hanan Al-Kuwari. Their participation highlights the commitment to advancing immunisation efforts in the region.

Political Commitment and Immunisation Awareness

Fostering political commitment and raising awareness about the importance of immunisation is essential. This is crucial for sustaining health achievements and preparing for future pandemics. In fragile, conflict-affected, and vulnerable countries, health care systems are often severely disrupted. This disruption severely impacts primary health care and immunisation services. The COVID-19 pandemic intensified these challenges, leading to growing immunity gaps.

Overall Goal

In conclusion, the framework aims to strengthen immunisation efforts, ensuring equitable access to vaccines and essential health services for all people in the region. With the support of Member States, the framework will strengthen immunisation services across the region. This initiative aligns with the broader goal of enabling all individuals in the Eastern Mediterranean to lead the healthiest lives possible. This will save lives and improve health outcomes for millions.

Reference url

Recent Posts

Hepcludex HDV approval
Hepcludex HDV Approval: A Breakthrough in Chronic Hepatitis Delta Treatment

By João L. Carapinha

May 25, 2026

The U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection as the first treatment for chronic hepatitis delta virus (HDV) infection in adults without cirrhosis or with compensated cirrhosis. This Hepcludex HDV approval addresses a previously unmet need for patients faci...
CHMP recommendations 2026
CHMP Recommendations 2026: New Approvals and Implications for Health Economics
The CHMP recommendations 2026 from the 18–21 May meeting delivered eight positive opinions for new medicines, thirteen extensions of therapeutic indications, and one negative opinion. These decisions bring meaningful progress in areas with significant unmet need, most notably idiopathic pulmonary...
clinical trial monitoring
Clinical Trial Monitoring: Insights from Q1 2026 EU/EEA Report

By HEOR Staff Writer

May 22, 2026

Clinical trial monitoring shows that in the first quarter of 2026, an average of 208 new clinical trial applications were submitted monthly through the Clinical Trials Information System, yielding 668 total submissions of which 538 received authorisation. The median time from submission to decisi...